Jd Health Intl Stock Price To Sales
| 8ZN Stock | 3.34 0.12 3.73% |
JD HEALTH INTL fundamentals help investors to digest information that contributes to JD HEALTH's financial success or failures. It also enables traders to predict the movement of 8ZN Stock. The fundamental analysis module provides a way to measure JD HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to JD HEALTH stock.
8ZN |
JD HEALTH INTL Company Price To Sales Analysis
JD HEALTH's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, JD HEALTH INTL has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Medical Care Facilities (which currently averages 0.0) industry. The price to sales for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
8ZN Fundamentals
| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0099 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.02) % | |||
| Shares Outstanding | 3.18 B | |||
| Shares Owned By Insiders | 68.29 % | |||
| Shares Owned By Institutions | 9.95 % | |||
| Revenue | 37.27 B | |||
| Gross Profit | 7.2 B | |||
| EBITDA | (730.33 M) | |||
| Book Value Per Share | 13.33 X | |||
| Earnings Per Share | (0.05) X | |||
| Number Of Employees | 2.54 K | |||
| Beta | 0.65 | |||
| Market Capitalization | 21.91 B |
About JD HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze JD HEALTH INTL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JD HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JD HEALTH INTL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in 8ZN Stock
JD HEALTH financial ratios help investors to determine whether 8ZN Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 8ZN with respect to the benefits of owning JD HEALTH security.